These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1272639)

  • 1. Enzymatic diagnosis and carrier detection of aspartylglucosaminuria using blood samples.
    Aula P; Raivio K; Autio S
    Pediatr Res; 1976 Jun; 10(6):625-9. PubMed ID: 1272639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal diagnosis and fetal pathology of aspartylglucosaminuria.
    Aula P; Rapola J; von Koskull H; Ammälä P
    Am J Med Genet; 1984 Oct; 19(2):359-67. PubMed ID: 6507482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gaucher disease: accurate identification of asymptomatic French-Canadian carrier using nonlabeled authentic sphingolipid substrate N-palmitoyl dihydroglucocerebroside.
    Choy FY; Bouillon L; Laurin CA
    Am J Med Genet; 1987 Aug; 27(4):895-905. PubMed ID: 3425599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory detection of aspartylglycosaminuria.
    Mononen I; Kaartinen V; Mononen T
    Scand J Clin Lab Invest Suppl; 1988; 191():7-11. PubMed ID: 3247584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A family with two children diagnosed with aspartylglucosaminuria-case report and literature review].
    Liu Y; Zou L; Meng Y; Zhang Y; Shi X; Ju J; Yang G; Hu L; Chen X
    Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):455-9. PubMed ID: 25190167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hurler syndrome: alpha-L-iduronidase activity in leukocytes as a method for heterozygote detection.
    Wappner RS; Brandt IK
    Pediatr Res; 1976 Jun; 10(6):629-32. PubMed ID: 818611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carrier detection of sialidosis with partial beta-galactosidase deficiency by the assay of lysosomal sialidase in lymphocytes.
    Tsuji S; Yamada T; Ariga T; Toyoshima I; Yamaguchi H; Kitahara Y; Miyatake T; Yamakawa T
    Ann Neurol; 1984 Feb; 15(2):181-3. PubMed ID: 6703657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linkage of aspartylglucosaminuria (AGU) to marker loci on the long arm of chromosome 4.
    Grön K; Aula P; Peltonen L
    Hum Genet; 1990 Jul; 85(2):233-6. PubMed ID: 1973404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzymatic determination of urinary aspartylglycosylamine: a rapid and sensitive-method to detect aspartylclycosylaminuria (AGU).
    Sugahara K; Nishimura K; Aula P; Yamashina IY
    Clin Chim Acta; 1976 Oct; 72(2):265-7. PubMed ID: 987869
    [No Abstract]   [Full Text] [Related]  

  • 10. Dissection of the molecular pathology of aspartylglucosaminuria provides the basis for DNA diagnostics and future therapeutic interventions.
    Ikonen E; Syvänen AC; Peltonen L
    Scand J Clin Lab Invest Suppl; 1993; 213():19-27. PubMed ID: 8322015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in N-acetyl-B-D-glucosaminidase and B-glucuronidase activities in milk during bovine mastitis.
    Nagahata H; Saito S; Noda H
    Can J Vet Res; 1987 Jan; 51(1):126-34. PubMed ID: 3567747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspartylglucosaminuria in the United States.
    Hreidarsson S; Thomas GH; Valle DL; Stevenson RE; Taylor H; McCarty J; Coker SB; Green WR
    Clin Genet; 1983 Jun; 23(6):427-35. PubMed ID: 6883788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus-mediated gene transfer results in decreased lysosomal storage in brain and total correction in liver of aspartylglucosaminuria (AGU) mouse.
    Peltola M; Kyttälä A; Heinonen O; Rapola J; Paunio T; Revah F; Peltonen L; Jalanko A
    Gene Ther; 1998 Oct; 5(10):1314-21. PubMed ID: 9930336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspartylglucosaminuria among Palestinian Arabs.
    Zlotogora J; Ben-Neriah Z; Abu-Libdeh BY; Sury V; Zeigler M
    J Inherit Metab Dis; 1997 Nov; 20(6):799-802. PubMed ID: 9427148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations causing aspartylglucosaminuria (AGU): a lysosomal accumulation disease.
    Ikonen E; Peltonen L
    Hum Mutat; 1992; 1(5):361-5. PubMed ID: 1301945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iduronate sulfatase activity in serum, lymphocytes, and fibroblasts--simplified diagnosis of the Hunter syndrome.
    Liebaers I; Neufeld E
    Pediatr Res; 1976 Aug; 10(8):733-6. PubMed ID: 821034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Skeletal changes in 2 German children with aspartylglycosaminuria].
    Schmidt H; Ziegler R; Ullrich K; von Lengerke JH; Sewell AC
    Rofo; 1988 Aug; 149(2):143-6. PubMed ID: 2842830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterozygote detection in Fabry disease utilizing multiple enzyme activities.
    Sheth KJ; Good TA; Murphy JV
    Am J Med Genet; 1981; 10(2):141-6. PubMed ID: 6274191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel aspartylglucosaminuria mutation affects translocation of aspartylglucosaminidase.
    Saarela J; von Schantz C; Peltonen L; Jalanko A
    Hum Mutat; 2004 Oct; 24(4):350-1. PubMed ID: 15365992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human aspartylglucosaminidase. A biochemical and immunocytochemical characterization of the enzyme in normal and aspartylglucosaminuria fibroblasts.
    Enomaa N; Heiskanen T; Halila R; Sormunen R; Seppälä R; Vihinen M; Peltonen L
    Biochem J; 1992 Sep; 286 ( Pt 2)(Pt 2):613-8. PubMed ID: 1530592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.